PQQ vs CoQ10: Best Supplement for Mitochondria?

Mike HartnettEvidence-Based

7+ years researching longevity protocols. Runs a 20+ supplement daily stack. Built CoreStacks after losing his father to heart disease.

Affiliate Disclosure: CoreStacks may earn a commission on purchases made through links in this article, at no extra cost to you.

PQQ vs CoQ10 at a Glance

What Is PQQ?

Pyrroloquinoline quinone is a redox cofactor found in trace amounts in foods like natto, parsley, green peppers, and kiwi. The supplement world latched onto PQQ for one reason: it activates PGC-1α, the master regulator of mitochondrial biogenesis. In plain English, PQQ tells your cells to build brand new mitochondria. That’s a big deal on paper, because mitochondrial decline is one of the hallmarks of aging.

The mechanism is genuinely interesting. PQQ triggers signaling cascades that upregulate PGC-1α expression, which then drives the transcription of genes responsible for mitochondrial replication and function. Animal studies have shown increased mitochondrial density in tissues of PQQ-supplemented mice. A small 2012 study in the Journal of Nutritional Biochemistry found that PQQ at 20 mg/day improved markers of mitochondrial function and reduced inflammation in healthy adults over 8 weeks.

Here’s the catch. The human evidence is thin. We’re talking about a handful of small trials with short durations. Nobody has done a large-scale, long-term randomized controlled trial on PQQ. The doses used in studies (10–20 mg) are tiny compared to something like CoQ10, and it’s unclear whether those doses meaningfully increase mitochondrial number in humans versus what we see in cell cultures and rodent models. The promise is real. The proof isn’t there yet.

What Is CoQ10?

Coenzyme Q10 is a fat-soluble compound that sits in your mitochondrial inner membrane and shuttles electrons through the electron transport chain. Without CoQ10, your mitochondria can’t produce ATP efficiently. It’s that fundamental. Your body makes CoQ10 naturally, but production declines with age — and that decline correlates directly with reduced cellular energy output and increased oxidative damage.

CoQ10 has been studied extensively since the 1970s. Hundreds of clinical trials. The cardiovascular data is particularly strong. The Q-SYMBIO trial — a 2014 randomized controlled trial published in JACC: Heart Failure — found that CoQ10 at 300 mg/day significantly reduced major adverse cardiovascular events and all-cause mortality in heart failure patients over two years. That’s the kind of hard endpoint data that PQQ can only dream about. For a complete breakdown of the research, see our CoQ10 supplementation guide.

The supplement comes in two forms: ubiquinone (oxidized) and ubiquinol (reduced). Ubiquinol is the active form with substantially better absorption. Peter Attia has discussed CoQ10 on The Drive podcast, noting its importance for mitochondrial function and its particular relevance for people on statin medications, which deplete CoQ10. Brad Stanfield has reviewed the evidence on his YouTube channel and considers CoQ10 one of the better-supported longevity supplements. For product recommendations, check our best CoQ10 ubiquinol guide.

Key Differences Between PQQ and CoQ10

New Mitochondria vs. Better Mitochondria

This is the fundamental distinction. PQQ’s claim to fame is mitochondrial biogenesis — creating entirely new mitochondria. CoQ10 makes your existing mitochondria work better by keeping the electron transport chain running efficiently. Think of it this way: PQQ is building new power plants, CoQ10 is fueling the ones you’ve already got. Both matter, but you need the fuel before you need more plants. Our NMN vs CoQ10 comparison covers the broader mitochondrial supplement field.

Evidence Gap

This is where the conversation gets blunt. CoQ10 has over 50 years of research, hundreds of randomized controlled trials, and hard clinical endpoint data including mortality reduction. PQQ has a few small human trials with surrogate markers. One supplement has earned its reputation through rigorous science. The other is riding on exciting mechanism-of-action data that hasn’t been validated at scale in humans. I want PQQ to deliver on its promise. But wanting isn’t evidence.

Dosing Confidence

CoQ10 dosing is well-established. For general health: 100–200 mg/day of ubiquinol. For cardiovascular support: 200–300 mg/day. For statin users: 100–200 mg/day minimum. These numbers come from clinical trials with thousands of participants. PQQ dosing is essentially guesswork based on a handful of studies. Is 10 mg enough? Is 20 mg better? Would 40 mg do something completely different? Nobody knows because the dose-response data doesn’t exist.

Cost Efficiency

CoQ10 (ubiquinol form) runs $25–50/month for a clinically validated dose. PQQ costs $15–30/month. PQQ is cheaper, but you’re paying for an unproven hypothesis. CoQ10 costs more but delivers measurable outcomes. Dollar for dollar, the supplement with actual clinical proof is the better investment. For how these fit into broader stacks, see our expert stacks comparison.

Can You Stack PQQ and CoQ10?

Yes, and this is actually the best use case for PQQ. If you’re already taking CoQ10, adding PQQ gives you both sides of the mitochondrial equation — more mitochondria (PQQ) and better-functioning mitochondria (CoQ10). Several supplement brands sell them as a combo product for this exact reason.

A 2013 study found that the combination of PQQ and CoQ10 improved cognitive function more than either supplement alone, though this was a small trial and needs replication. The logic is sound: CoQ10 powers the mitochondria you have, PQQ signals your body to produce additional ones, and together they could theoretically produce a compounding effect on cellular energy. Use our supplement interaction checker to verify how both fit with your current stack.

Bottom line: if you’re only going to take one, make it CoQ10. If you’ve got CoQ10 covered and want to push further into the mitochondrial optimization space, PQQ at 20 mg/day is a reasonable addition. Just know you’re making a bet on early science.

What Experts Say

Peter Attia has discussed CoQ10 on The Drive podcast in the context of mitochondrial health and cardiovascular function. He’s noted the Q-SYMBIO trial results and the particular importance of CoQ10 supplementation for statin users, given that statins inhibit the mevalonate pathway that produces both cholesterol and CoQ10. His full longevity approach is in our Attia protocol breakdown.

Brad Stanfield has reviewed both PQQ and CoQ10 in his evidence-based supplement analyses on YouTube. He’s given CoQ10 (ubiquinol) a favorable evidence rating while flagging PQQ as “interesting but insufficient evidence for a strong recommendation.” He emphasizes that mechanism-of-action data, no matter how compelling, isn’t a substitute for clinical trials. See his full protocol in our Stanfield protocol breakdown.

The longevity research community broadly acknowledges mitochondrial biogenesis as a key target for anti-aging interventions. Exercise remains the best-proven biogenesis stimulus — far more effective than any supplement. PQQ’s ability to activate PGC-1α is real, but so does exercise, cold exposure, and caloric restriction, all with vastly more evidence. For exercise-based longevity strategies, see our heart health supplements guide which covers the cardio connection.

Which Should You Choose?

Go with CoQ10 if you:

• Want the mitochondrial supplement with the strongest clinical evidence
• Take a statin medication (CoQ10 is nearly essential in this case)
• Have cardiovascular health concerns — the Q-SYMBIO trial data is compelling
• Prefer a supplement where dosing has been validated across hundreds of trials
• Are building your first longevity stack and need high-impact choices — see our Attia protocol for how CoQ10 fits

Go with PQQ if you:

• Already take CoQ10 and want to add a mitochondrial biogenesis angle
• Are interested in emerging longevity science and comfortable with limited human data
• Have budget room after covering the foundational supplements
• Want cognitive support (the small amount of data leans in this direction)
• Understand you’re investing in a promising hypothesis, not a proven therapy

My take: CoQ10 (ubiquinol, 200 mg/day) has been in my stack for a while and I consider it foundational. I experimented with PQQ at 20 mg/day for three months. Honestly, I couldn’t point to any noticeable difference. That doesn’t mean it wasn’t working at the cellular level — mitochondrial biogenesis isn’t something you’d feel day-to-day — but it also means I can’t give you a personal testimonial. The science is intriguing enough that I’d take it again if someone handed it to me, but I’m not spending my own money on it when CoQ10, omega-3s, and creatine are already doing heavy lifting.

Frequently Asked Questions

Related Comparisons

Looking for more supplement comparisons? Check out our CoQ10 vs ALA.

This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement regimen.